269 related articles for article (PubMed ID: 11826020)
1. A single amino acid substitution (D1441Y) in the carboxyl-terminal propeptide of the proalpha1(I) chain of type I collagen results in a lethal variant of osteogenesis imperfecta with features of dense bone diseases.
Pace JM; Chitayat D; Atkinson M; Wilcox WR; Schwarze U; Byers PH
J Med Genet; 2002 Jan; 39(1):23-9. PubMed ID: 11826020
[TBL] [Abstract][Full Text] [Related]
2. Disruption of one intra-chain disulphide bond in the carboxyl-terminal propeptide of the proalpha1(I) chain of type I procollagen permits slow assembly and secretion of overmodified, but stable procollagen trimers and results in mild osteogenesis imperfecta.
Pace JM; Kuslich CD; Willing MC; Byers PH
J Med Genet; 2001 Jul; 38(7):443-9. PubMed ID: 11432962
[TBL] [Abstract][Full Text] [Related]
3. Mutations in the carboxyl-terminal propeptide of the pro alpha 1(I) chain of type I collagen result in defective chain association and produce lethal osteogenesis imperfecta.
Chessler SD; Wallis GA; Byers PH
J Biol Chem; 1993 Aug; 268(24):18218-25. PubMed ID: 8349697
[TBL] [Abstract][Full Text] [Related]
4. COL1 C-propeptide cleavage site mutations cause high bone mass osteogenesis imperfecta.
Lindahl K; Barnes AM; Fratzl-Zelman N; Whyte MP; Hefferan TE; Makareeva E; Brusel M; Yaszemski MJ; Rubin CJ; Kindmark A; Roschger P; Klaushofer K; McAlister WH; Mumm S; Leikin S; Kessler E; Boskey AL; Ljunggren O; Marini JC
Hum Mutat; 2011 Jun; 32(6):598-609. PubMed ID: 21344539
[TBL] [Abstract][Full Text] [Related]
5. Mutations in PPIB (cyclophilin B) delay type I procollagen chain association and result in perinatal lethal to moderate osteogenesis imperfecta phenotypes.
Pyott SM; Schwarze U; Christiansen HE; Pepin MG; Leistritz DF; Dineen R; Harris C; Burton BK; Angle B; Kim K; Sussman MD; Weis M; Eyre DR; Russell DW; McCarthy KJ; Steiner RD; Byers PH
Hum Mol Genet; 2011 Apr; 20(8):1595-609. PubMed ID: 21282188
[TBL] [Abstract][Full Text] [Related]
6. Defective C-propeptides of the proalpha2(I) chain of type I procollagen impede molecular assembly and result in osteogenesis imperfecta.
Pace JM; Wiese M; Drenguis AS; Kuznetsova N; Leikin S; Schwarze U; Chen D; Mooney SH; Unger S; Byers PH
J Biol Chem; 2008 Jun; 283(23):16061-7. PubMed ID: 18375391
[TBL] [Abstract][Full Text] [Related]
7. Type I procollagen C-propeptide defects: study of genotype-phenotype correlation and predictive role of crystal structure.
Symoens S; Hulmes DJ; Bourhis JM; Coucke PJ; De Paepe A; Malfait F
Hum Mutat; 2014 Nov; 35(11):1330-41. PubMed ID: 25146735
[TBL] [Abstract][Full Text] [Related]
8. Mutations That Alter the Carboxy-Terminal-Propeptide Cleavage Site of the Chains of Type I Procollagen Are Associated With a Unique Osteogenesis Imperfecta Phenotype.
Cundy T; Dray M; Delahunt J; Hald JD; Langdahl B; Li C; Szybowska M; Mohammed S; Duncan EL; McInerney-Leo AM; Wheeler PG; Roschger P; Klaushofer K; Rai J; Weis M; Eyre D; Schwarze U; Byers PH
J Bone Miner Res; 2018 Jul; 33(7):1260-1271. PubMed ID: 29669177
[TBL] [Abstract][Full Text] [Related]
9. Endoplasmic reticulum-mediated quality control of type I collagen production by cells from osteogenesis imperfecta patients with mutations in the pro alpha 1 (I) chain carboxyl-terminal propeptide which impair subunit assembly.
Lamandé SR; Chessler SD; Golub SB; Byers PH; Chan D; Cole WG; Sillence DO; Bateman JF
J Biol Chem; 1995 Apr; 270(15):8642-9. PubMed ID: 7721766
[TBL] [Abstract][Full Text] [Related]
10. Heterozygous C-propeptide mutations in COL1A1: osteogenesis imperfecta type IIC and dense bone variant.
Takagi M; Hori N; Chinen Y; Kurosawa K; Tanaka Y; Oku K; Sakata H; Fukuzawa R; Nishimura G; Spranger J; Hasegawa T
Am J Med Genet A; 2011 Sep; 155A(9):2269-73. PubMed ID: 21834035
[TBL] [Abstract][Full Text] [Related]
11. Severe osteogenesis imperfecta caused by double glycine substitutions near the amino-terminal triple helical region in COL1A2.
Takagi M; Shinohara H; Narumi S; Nishimura G; Hasegawa Y; Hasegawa T
Am J Med Genet A; 2015 Jul; 167(7):1627-31. PubMed ID: 25858481
[TBL] [Abstract][Full Text] [Related]
12. The phenotypic features of osteogenesis imperfecta resulting from a mutation of the carboxyl-terminal pro alpha 1 (I) propeptide that impairs the assembly of type I procollagen and formation of the extracellular matrix.
Cole WG; Chow CW; Bateman JF; Sillence DO
J Med Genet; 1996 Nov; 33(11):965-7. PubMed ID: 8950680
[TBL] [Abstract][Full Text] [Related]
13. The clinical features of osteogenesis imperfecta resulting from a non-functional carboxy terminal pro alpha 1(I) propeptide of type I procollagen and a severe deficiency of normal type I collagen in tissues.
Cole WG; Campbell PE; Rogers JG; Bateman JF
J Med Genet; 1990 Sep; 27(9):545-51. PubMed ID: 2121988
[TBL] [Abstract][Full Text] [Related]
14. Helical mutations in type I collagen that affect the processing of the amino-propeptide result in an Osteogenesis Imperfecta/Ehlers-Danlos Syndrome overlap syndrome.
Malfait F; Symoens S; Goemans N; Gyftodimou Y; Holmberg E; López-González V; Mortier G; Nampoothiri S; Petersen MB; De Paepe A
Orphanet J Rare Dis; 2013 May; 8():78. PubMed ID: 23692737
[TBL] [Abstract][Full Text] [Related]
15. A lethal variant of osteogenesis imperfecta has a single base mutation that substitutes cysteine for glycine 904 of the alpha 1(I) chain of type I procollagen. The asymptomatic mother has an unidentified mutation producing an overmodified and unstable type I procollagen.
Constantinou CD; Nielsen KB; Prockop DJ
J Clin Invest; 1989 Feb; 83(2):574-84. PubMed ID: 2913053
[TBL] [Abstract][Full Text] [Related]
16. Substitutions of aspartic acid for glycine-220 and of arginine for glycine-664 in the triple helix of the pro alpha 1(I) chain of type I procollagen produce lethal osteogenesis imperfecta and disrupt the ability of collagen fibrils to incorporate crystalline hydroxyapatite.
Culbert AA; Lowe MP; Atkinson M; Byers PH; Wallis GA; Kadler KE
Biochem J; 1995 Nov; 311 ( Pt 3)(Pt 3):815-20. PubMed ID: 7487936
[TBL] [Abstract][Full Text] [Related]
17. Mutations in the COL1A1 and COL1A2 genes associated with osteogenesis imperfecta (OI) types I or III.
Augusciak-Duma A; Witecka J; Sieron AL; Janeczko M; Pietrzyk JJ; Ochman K; Galicka A; Borszewska-Kornacka MK; Pilch J; Jakubowska-Pietkiewicz E
Acta Biochim Pol; 2018; 65(1):79-86. PubMed ID: 29543922
[TBL] [Abstract][Full Text] [Related]
18. COL1A1 C-propeptide mutations cause ER mislocalization of procollagen and impair C-terminal procollagen processing.
Barnes AM; Ashok A; Makareeva EN; Brusel M; Cabral WA; Weis M; Moali C; Bettler E; Eyre DR; Cassella JP; Leikin S; Hulmes DJS; Kessler E; Marini JC
Biochim Biophys Acta Mol Basis Dis; 2019 Sep; 1865(9):2210-2223. PubMed ID: 31055083
[TBL] [Abstract][Full Text] [Related]
19. A single base mutation that converts glycine 907 of the alpha 2(I) chain of type I procollagen to aspartate in a lethal variant of osteogenesis imperfecta. The single amino acid substitution near the carboxyl terminus destabilizes the whole triple helix.
Baldwin CT; Constantinou CD; Dumars KW; Prockop DJ
J Biol Chem; 1989 Feb; 264(5):3002-6. PubMed ID: 2914942
[TBL] [Abstract][Full Text] [Related]
20. Molecular heterogeneity in osteogenesis imperfecta type I.
Willing MC; Pruchno CJ; Byers PH
Am J Med Genet; 1993 Jan; 45(2):223-7. PubMed ID: 8456806
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
